HeraMED Limited announced that it has signed a Letter of Intent (LOI) with Teleperinatal to deploy the HeraCARE mobile maternal care app and the HeraBEAT smart fetal HR monitor, under an initial paid pilot for six months. Assuming a successful pilot, both parties intend to progress to a formal commercial agreement. Teleperinatal provides a maternity benefits program for employers that is designed to reduce the cost of pregnancy care by giving employees direct, virtual access to Maternal-Fetal Medicine physicians, who will serve as advocates throughout the pregnancy and postpartum period. The program represents an employer benefit and is being sold direct-to-employer, with an initial focus on Fortune 500 Companies and a launch scheduled in the first quarter of 2021. Several contracts have already been secured and expectations are for approximately 500,000 lives to be under management at by the end of 2021, and it is estimated this will include more than 10,000 pregnant women. Employers will offer access to the Teleperinatal pregnancy service, and in turn, Teleperinatal will deploy a co-branded HeraCARE mobile app and sell the HeraBEAT device. Under the terms of this agreement, Teleperinatal will pay a licence fee for the HeraCARE platform of USD 5 per month per active user and will offer its users the HeraBEAT device for an additional USD 29 per month fee.